P11.61 Development of a novel preclinical GBM model and therapeutic impact of IRE1 inhibition

Glioblastoma Multiforme (GBM) is the most severe primary brain tumor and represents more than 15% of all brain tumors. Despite an aggressive treatment comprising surgical resection and radio/chemotherapy, patient’s survival post diagnosis remains short with a median overall survival of 15 months. Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Le Reste, P, Pineau, R, Jouan, F, Samal, J, Jegou, G, Patterson, J, Vauleon, E, Avril, T, Pandit, A, Chevet, E
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796129/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados